FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:646-647 February 5, 2009 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

By Richard Kradin. 278 pp., illustrated. New York, Routledge, 2008. $40. ISBN 978-0-415-95618-5.

Richard Kradin, as he explains in the acknowledgements section of his book, sets out to develop "an explanatory model for the placebo response," with a particular interest in mind–body physiology and the possible mechanisms of the response — meaning beneficial responses to the fact of treatment, rather than to the treatment itself. Kradin does indeed describe in detail various beliefs about and explanations of placebo responses. One difficulty in attempts to explain and analyze placebo effects, as Kradin recognizes at least some of the time, is that the response is not measured in clinical trials. What we measure is the . . . [Full Text of this Article]

This article has been cited by other articles:

• Scheindlin, S. (2009). The Problematic Placebo. Mol. Interv. 9: 108-113 [Full Text]